Hormone replacement therapy is associated with reduced hepatocellular carcinoma risk and improved survival in postmenopausal women with hepatitis B: A nationwide long-term populati...

por Wang, Chun-Hsiang, Lin, Ruey-Chang, Hsu, Hua-Yin, Tseng, Yuan-Tsung
Publicado 2022

Consolidation period of 18 months no better at promoting off-treatment durability in HBeAg-positive chronic hepatitis B patients with tenofovir disoproxil fumarate treatment than a...

por Wang, Chun-Hsiang, Chang, Kuo-Kuan, Lin, Ruey-Chang, Kuo, Ming-Jeng, Yang, Chi-Chieh, Tseng, Yuan-Tsung
Publicado 2020